Biote Corp BTMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.09
- Day Range
- $1.05–1.10
- 52-Week Range
- $1.00–3.25
- Bid/Ask
- $0.80 / $1.44
- Shares Outstanding
- 28.68M
- Market Cap
- $30.69M
- Volume/Avg
- 67,833 / 222,952
Key Statistics
- Price/Earnings (Normalized)
- 22.33
- Price/Sales
- 0.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 29.28%
Company Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 223
- Website
- https://www.biote.com
Valuation
|
Metric
|
BTMD
|
|---|---|
Price/Earnings (Normalized) | 22.33 |
Price/Book Value | — |
Price/Sales | 0.20 |
Price/Cash Flow | 1.88 |
Price/Earnings
BTMD
Financial Strength
|
Metric
|
BTMD
|
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.43 |
Interest Coverage | 2.10 |
Quick Ratio
BTMD
Profitability
|
Metric
|
BTMD
|
|---|---|
Return on Assets (Normalized) | 9.19% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 30.56% |
Return on Assets
BTMD
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|@c | LOCK|PZ> | — | |||
| HCA Healthcare Inc
HCA
| LOCK|Mzx$Z%g | LOCK|#fV^ | $99B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|$Qw> | $28B | |||
| Tenet Healthcare Corp
THC
| LOCK|pHq#dz | LOCK|qy^X | $22B | |||
| Encompass Health Corp
EHC
| — | LOCK|Rv!fB | $13B | |||
| DaVita Inc
DVA
| LOCK|>#@?Xz | LOCK|?VL^ | $12B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|%X>? | $12B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|g<%jb& | LOCK|%Rk#z | $12B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|#$Dj<@< | LOCK|NN<bx | $11B | |||
| Ensign Group Inc
ENSG
| — | LOCK|ZdLQf | $10B |
United States